| Rivastigmine Transdermal System | Zydus Lifesciences Limited | 20251117 | 1 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 2000 | Northstar Rx LLC. | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20251114 | 7 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | American Health Packaging | 20251111 | 2 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20250401 | 102 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20250401 | 102 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20250327 | 111 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20250320 | 107 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20250319 | 106 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | Major Pharmaceuticals | 20250303 | 4 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Breckenridge Pharmaceutical, Inc. | Adhexpharma | 20250115 | 7 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20241224 | 100 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Mylan Pharmaceuticals Inc. | 20240921 | 10 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20240819 | 108 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | 20240702 | 17 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | Aurobindo Pharma Limited | 20240619 | 9 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20240530 | 110 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 2000 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20240527 | 4 |
| These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 2000 | Novartis Pharmaceuticals Corporation | 20240508 | 30 |
| These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 2000 | Sandoz Inc | 20240508 | 1 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE TRANSDERMAL SYSTEM Initial U.S. Approval: 2000 | Sandoz Inc | 20240508 | 5 |
| Rivastigmine Tartrate Capsules, USP These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES, USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES, USP. RIVASTIGMINE tartrate capsules, USP for oral use Initial U.S. Approval: 2000 | Chartwell RX, LLC | Chartwell Pharmaceuticals Congers, LLC | 20231006 | 2 |
| These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use. Initial U.S. Approval: 2000 | Alembic Pharmaceuticals Limited | 20230116 | 3 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | Cadila Pharmaceuticals Limited | 20221229 | 6 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | Modavar Pharmaceuticals LLC | Cadila Pharmaceuticals Limited | 20221228 | 2 |
| These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 2000 | Zydus Lifesciences Limited | 20221004 | 3 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES . RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | Macleods Pharmaceuticals Limited | 20220824 | 7 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20220321 | 1 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | Nivagen Pharmaceuticals, Inc. | 20220216 | 3 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20190131 | 8 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited - FTO 3 | 20190123 | 9 |
| These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE tartrate capsules, for oral use Initial U.S. Approval: 2000 | Ajanta Pharma Limited | 20180219 | 7 |
| These highlights do not include all the information needed to use rivastigmine tartrate capsules safely and effectively. See full prescribing information for rivastigmine tartrate capsules. RIVASTIGMINE tartrate capsules, for oral use Initial U.S. Approval: 2000 | Carilion Materials Management | 20160806 | 4 |
| Exelon | Rebel Distributors Corp | 20101220 | 1 |
| Rivastigmine Tartrate Capsules | Physicians Total Care, Inc. | 20100628 | 1 |
| fead084a-a376-4d57-bdf0-aa7ed3655505 | Physicians Total Care, Inc. | 20100609 | 1 |
| 29481887-34eb-460a-bd7f-b8755473065a | Physicians Total Care, Inc. | 20100222 | 2 |